CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for BBS-Bioactive Bone Substitutes Oyj is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

BBS-Bioactive Bone Substitutes Oyj
Kiviharjunlenkki 6
Phone: +358 207924700p:+358 207924700 OULU, 90220  Finland Ticker: BONEHBONEH
Business Summary
BBS-Bioactive Bone Substitutes Oyj (BBS) is a Finland-based company engaged in the medical equipment industry. The Company operates as a biotechnology company that develops and distributes medical device implants used in orthopedic surgery. Its products include ARTEBONE, an orthopedic bone substitute material made from reindeer bone protein matrix made using a propriety patented manufacturing process that can be used in various application areas, such as bone regeneration, healing of fractures, non-unions, bone defect, dental implantation, orthopedics, maxillofacial/dental surgery and osteoporotic fractures.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
3842 Orthopedic, prosthetic, and surgical appliances and supplies

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board JarmoHalonen 66 1/1/2016 1/1/2016
Chief Executive Officer, Director IlkkaKangasniemi 58 10/15/2019 4/1/2019
Chief Financial Officer LiisaHukka 2/1/2021 2/1/2021
8 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 20,297,175 (As of 4/25/2024)
Stock Exchange: HEL


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 26, 2024